Synopsis
Filiada à International Diabetes Federation (IDF), a Sociedade Brasileira de Diabetes (SBD), é uma associação civil, sem fins lucrativos.
Episodes
-
P133 - Manejo do peso e remissão do DM2 - estudo DIRECT - Suzana Vieira
11/11/2019 Duration: 11minPrimary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018 Feb 10;391(10120):541-551.
-
P132 - Mortalidade após controle dos fatores de risco DCV no DM2 - Wellington Santana
01/11/2019 Duration: 06minRisk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2018 Aug 16;379(7):633-644
-
P131 - Intervenção precoce da DCV no DM2 - Fábio Trujilho
25/10/2019 Duration: 09minP131 - Intervenção precoce da DCV no DM2 - Fábio Trujilho by SBD
-
P130 - Complicações microvasculares - Luís Canani
17/10/2019 Duration: 09minP130 - Complicações microvasculares - Luís Canani by SBD
-
P129 - Dos guidelines à prática clínica - Maria Helane Gurgel Castelo
10/10/2019 Duration: 10minP129 - Dos guidelines à prática clínica - Maria Helane Gurgel Castelo by SBD
-
Podcast 128 - Complicações macrovasculares - Cynthia Valerio
04/10/2019 Duration: 08minPodcast 128 - Complicações macrovasculares - Cynthia Valerio by SBD
-
P127 - Hipoglicemia e desfechos CV - João Roberto de Sá
27/09/2019 Duration: 09minP127 - Hipoglicemia e desfechos CV - João Roberto de Sá by SBD
-
P126 - Diagnóstico e manejo do DM2 - Rosângela Réa
18/09/2019 Duration: 10minP126 - Diagnóstico e manejo do DM2 - Rosângela Réa by SBD
-
P125 - Relação dose de insulina basal e controle glicêmico em DM2 - Fernando Valente
26/08/2019 Duration: 05minRef: When basal insulin is not enough: A dose-response relationship between insulin glargine 100 units/mL and glycaemic control. Diabetes Obes Metab. 2019 Jun;21(6):1305-1310.
-
P124 - Semaglutida em DM2 com insulina - estudo SUSTAIN 5 - Luciano Giacaglia
19/08/2019 Duration: 09minRef: Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial. J Clin Endocrinol Metab. 2018 Jun 1;103(6):2291-2301.
-
P123 - Segurança CV da Dulaglutida - estudo REWIND - Roberto Betti
08/08/2019 Duration: 03minRef: Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 Jul 13;394(10193):121-130.
-
P122 - Consumo de bebidas açucaradas e mortalidade - Bianca de Almeida Pitito
01/07/2019 Duration: 07minRef: Association of Sugary Beverage Consumption With Mortality Risk in US Adults: A Secondary Analysis of Data From the REGARDS Study. JAMA Netw Open. 2019 May 3;2(5):e193121.
-
P121 - Incidência e prevalência de DM nos EUA - Bianca de Almeida Pitito
19/06/2019 Duration: 05minNew directions in incidence and prevalence of diagnosed diabetes in the USA. BMJ Open Diab Res Care 2019;7:e000657.
-
P120 - Metformina na prevenção de DM2 - seguimento DPP - Fernando Valente
10/06/2019 Duration: 07minRef: Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2019 Apr;42(4):601-608.
-
P119 - Hipolipemiante reduz risco de retinopatia em DM2 - Solange Travassos
21/05/2019 Duration: 05minLipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database. Diabetes Obes Metab. 2018 Oct;20(10):2351-2360.
-
P118 - Canagliflozina em DM2 e DRC - estudo CREDENCE - Mateus Dornelles Severo
13/05/2019 Duration: 11minRef: Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl J Med. 2019 Apr 14.
-
P117 - Relação A1c e tempo no alvo - Mônica Gabbay
30/04/2019 Duration: 06minThe Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technol Ther. 2019 Feb;21(2):81-85.
-
P116 - Associação hipoglicemia bioquímica e hipoglicemia grave - Mônica Gabbay
15/04/2019 Duration: 07minThe Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set. Diabetes Technol Ther. 2019 Jan;21(1):1-5.
-
P115 - Comparação de desfechos CV e renais aGLP1 e iSGLT2 - Euler Manenti
08/03/2019 Duration: 09minComparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials. Circulation. 2019 Feb 21.
-
P114 - Irisina ligada ao exercício melhora memória de modelos de Alzheimer - João E. Nunes Salles
14/02/2019 Duration: 04minExercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models. Nat Med. 2019 Jan;25(1):165-175.